<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1028-4818</journal-id>
<journal-title><![CDATA[Multimed]]></journal-title>
<abbrev-journal-title><![CDATA[Multimed]]></abbrev-journal-title>
<issn>1028-4818</issn>
<publisher>
<publisher-name><![CDATA[Centro Provincial de Información de Ciencias Médicas]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1028-48182020000501210</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Tumor virilizante gigante de células de la granulosa de ovario izquierdo. Caso clínico]]></article-title>
<article-title xml:lang="en"><![CDATA[Giant virilizing tumor of left ovarian granulose cells. Clinical case]]></article-title>
<article-title xml:lang="pt"><![CDATA[Tumor virilizador gigante de células de granulose ovariana esquerda. Caso clínico]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Malcolm Suárez.]]></surname>
<given-names><![CDATA[Adolfo Luis]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Díaz Juan.]]></surname>
<given-names><![CDATA[Gricel Liliana]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Leyva Fonseca.]]></surname>
<given-names><![CDATA[Dayana]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad de Ciencias Médicas de Granma Hospital General Docente Universitario Carlos Manuel de Céspedes ]]></institution>
<addr-line><![CDATA[Bayamo Granma]]></addr-line>
<country>Cuba</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Facultad de Ciencias Médicas Efraín Pompa Benítez  ]]></institution>
<addr-line><![CDATA[Bayamo Granma]]></addr-line>
<country>Cuba</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>10</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>10</month>
<year>2020</year>
</pub-date>
<volume>24</volume>
<numero>5</numero>
<fpage>1210</fpage>
<lpage>1220</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S1028-48182020000501210&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_abstract&amp;pid=S1028-48182020000501210&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_pdf&amp;pid=S1028-48182020000501210&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN Los tumores productores de esteroides ováricos constituyen entidades infrecuentes y son potencialmente malignos. La testosterona es la hormona que se eleva con más frecuencia y se asocia en su mayoría a signos de virilización. Se diagnosticó un caso de una paciente de 62 años con tumor gigante virilizante de células de la granulosa de ovario. Se realizo laparotomía programada con biopsia por congelación e histerectomía total abdominal con doble anixectomía más omentectomía. Evoluciono favorablemente sin complicaciones.El caso que aquí se reporta es el de una paciente con antecedentes de salud aparente, menstruaciones regulares, con antecedentes obstétricos de 4 gestaciones y de haber sido operada a los 24 años de un óbito fetal de mellizos, ante un cuadro de síndrome de virilización se utilizaron los datos provenientes de la historia clínica hospitalaria, exámenes complementarios, la entrevista y el examen físico de la paciente. A pesar del tiempo de evolución que presentaba la paciente con el tumor virilizante gigante de células de la granulosa de ovario izquierdo, la operación fue un éxito y la evolución ha sido satisfactoria, gracias a la labor del personal médico que estuvo a cargo del caso, demostrando una vez más las fortalezas del sistema cubano de salud ante situaciones como estas.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT Peripheral steroid-producing tumors are rare entities and are potentially malignant. Testosterone is the most commonly elevated hormone and is mostly associated with signs of virilization. A case of a 62-year-old patient with a giant virilizing ovarian granulose cell tumor was diagnosed. Scheduled laparotomy was performed with freezing biopsy and total abdominal hysterectomy with double anixectomy plus omentectomy. I evolve favorably without complications. The case reported here is that of a patient with a history of apparent health, regular menstruations, with an obstetric history of 4 gestations and having been operated on at 24 years of a fetal heart rate, before a table of virilization syndrome were used data from hospital medical history, complementary examinations, interview and physical examination of the patient. Despite the time of evolution presented by the patient with the giant virilizing tumor of cells of the left ovary granulose, the operation was a success and the evolution has been satisfactory, thanks to the work of the medical staff who were in charge of the case, demonstrating once again the strengths of the Cuban health system in situations like these.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[RESUMO Tumores periféricos produtores de esteroides são entidades raras e são potencialmente malignos. A testosterona é o hormônio mais comumente elevado e está principalmente associado com sinais de virilização. Um caso de um paciente de 62 anos com um tumor gigante de células de granulose ovariana foi diagnosticado. A laparotomia programada foi realizada com biópsia congelante e histerectomia abdominal total com anixectomia dupla mais omentectomia. Eu evoluo favoravelmente sem complicações. O caso aqui relatado é o de um paciente com histórico de saúde aparente, menstruações regulares, com histórico obstétrico de 4 gestações e tendo sido operado aos 24 anos de frequência cardíaca fetal, antes de uma tabela de síndrome de virilização ser utilizado dados do histórico médico hospitalar, exames complementares, entrevista e exame físico do paciente. Apesar do tempo de evolução apresentado pelo paciente com o tumor virilizador gigante de células do ovário esquerdo granulose, a operação foi um sucesso e a evolução tem sido satisfatória, graças ao trabalho da equipe médica responsável pelo caso, demonstrando mais uma vez os pontos fortes do sistema de saúde cubano em situações como essas.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Tumores ováricos]]></kwd>
<kwd lng="es"><![CDATA[Virilización]]></kwd>
<kwd lng="es"><![CDATA[Células de la granulosa]]></kwd>
<kwd lng="en"><![CDATA[Peripheral tumors]]></kwd>
<kwd lng="en"><![CDATA[Virilization]]></kwd>
<kwd lng="en"><![CDATA[Granulose cells]]></kwd>
<kwd lng="pt"><![CDATA[Tumores periféricos]]></kwd>
<kwd lng="pt"><![CDATA[Virilização]]></kwd>
<kwd lng="pt"><![CDATA[Células de granulose]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Huerta Sáenz]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Criterios sonogáficos de evaluación de malignidad de tumores de ovario Metodología IOTA (International Ovarian Tumor Analysis Group)]]></article-title>
<source><![CDATA[Rev Peru Ginecol Obstet]]></source>
<year>2019</year>
<volume>65</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>311-5</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jacobs]]></surname>
<given-names><![CDATA[IJ]]></given-names>
</name>
<name>
<surname><![CDATA[Menon]]></surname>
<given-names><![CDATA[U]]></given-names>
</name>
<name>
<surname><![CDATA[Ryan]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Gentry-Maharaj]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Burnell]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Kalsi]]></surname>
<given-names><![CDATA[JK]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Ovarian cancer screen-ing and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a ran-domised controlled trial]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>2016</year>
<volume>387</volume>
<numero>10022</numero>
<issue>10022</issue>
<page-range>945-56</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Timmerman]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Van Calster]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Testa]]></surname>
<given-names><![CDATA[AC]]></given-names>
</name>
<name>
<surname><![CDATA[Savelli]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Fischerova]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Froyman]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Predict-ing the risk of malignancy in adnexal masses based on the Simple Rules from the International Ovarian Tumor Analysis group]]></article-title>
<source><![CDATA[Am J Obstet Gynecol]]></source>
<year>2016</year>
<volume>214</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>424-37</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[YK]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[CT imaging of ovarian yolk sac tumor with emphasis on differential diagnosis]]></article-title>
<source><![CDATA[Sci Rep]]></source>
<year>2015</year>
<volume>5</volume>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cai-Yan]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical experience of uterine tumors resembling ovarian sex cord tumors: a clinic pathological analysis of 6 cases]]></article-title>
<source><![CDATA[Int J Clin Exp Pathol]]></source>
<year>2015</year>
<volume>8</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>4158-64</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Spinelli]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Pucci]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Strambi]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Lo Piccolo]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Martin]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Messineo]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Treatment of ovarian lesions in children and adolescents: a retrospective study of 130 cases]]></article-title>
<source><![CDATA[Pediatr Hematol Oncol]]></source>
<year>2015</year>
<volume>32</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>199-206</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Spinelli]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Strambi]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Liloia]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Bertocchini]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Messineo]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Update on the surgical management of ovarian neoplasms in children and adolescents: analysis on 32 cases]]></article-title>
<source><![CDATA[Gynecol Endocrinol]]></source>
<year>2016</year>
<volume>32</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>787-91</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mariampillai]]></surname>
<given-names><![CDATA[AI]]></given-names>
</name>
<name>
<surname><![CDATA[Cruz]]></surname>
<given-names><![CDATA[JPD]]></given-names>
</name>
<name>
<surname><![CDATA[Suh]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Sivapiragasam]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Nevins]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Hindenburg]]></surname>
<given-names><![CDATA[AA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cancer Antigen 72-4 for the Monitoring of Advanced Tumors of the Gastrointestinal Tract, Lung, Breast and Ovaries]]></article-title>
<source><![CDATA[Anticancer Res]]></source>
<year>2017</year>
<volume>37</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>3649-56</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Abbas]]></surname>
<given-names><![CDATA[PI]]></given-names>
</name>
<name>
<surname><![CDATA[Dietrich]]></surname>
<given-names><![CDATA[JE]]></given-names>
</name>
<name>
<surname><![CDATA[Francis]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Brandt]]></surname>
<given-names><![CDATA[ML]]></given-names>
</name>
<name>
<surname><![CDATA[Cass]]></surname>
<given-names><![CDATA[DL]]></given-names>
</name>
<name>
<surname><![CDATA[Lopez]]></surname>
<given-names><![CDATA[ME]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Ovarian-sparing surgery in pediatric benign ovarian tumors]]></article-title>
<source><![CDATA[J Pediatr Adolesc Gynecol]]></source>
<year>2016</year>
<volume>29</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>506-10</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Blake]]></surname>
<given-names><![CDATA[EA]]></given-names>
</name>
<name>
<surname><![CDATA[Sheridan]]></surname>
<given-names><![CDATA[TB]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[KL]]></given-names>
</name>
<name>
<surname><![CDATA[Takiuchi]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Kodama]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical characteristics and outcomes of uterine tumors resembling ovarian sex-cord tumors (UTROSCT): a systematic review of literature]]></article-title>
<source><![CDATA[Eur J Obstet Gynecol Reprod Biol]]></source>
<year>2014</year>
<volume>181</volume>
<numero>163-170</numero>
<issue>163-170</issue>
</nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<collab>Instituto Nacional del Cáncer</collab>
<article-title xml:lang=""><![CDATA[Tratamiento de los tumores extragonadales de células germinativas (PDQ(r))]]></article-title>
<source><![CDATA[Instituto Nacional del Cáncer]]></source>
<year>2014</year>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
